Clinical trial
Study Evaluating Drug Interaction Between Multiple Doses of Ketoconazole and a…
NCT00434486 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00434486 |
|---|---|
| Title | Study Evaluating Drug Interaction Between Multiple Doses of Ketoconazole and a Single Dose of SKI-606 |
| Official title | An Open-Label, Randomized, 2-Period Crossover Study to Evaluate the Potential Pharmacokinetic Interaction Between Multiple Doses of Ketoconazole and a Single Dose of SKI-606 Administered Orally to Healthy Subjects |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | SKI-606 |
| Enrollment | 24 |
| Start date | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Feb 13, 2007 |
| Last update posted | Sep 12, 2007 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: